Cribstone Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$348K Sell
950
-5
-0.5% -$1.77K 0.2% 89
2022
Q3
$309K Sell
955
-5
-0.5% -$1.58K 0.19% 91
2022
Q2
$311K Buy
960
+10
+1% +$3K 0.19% 86
2022
Q1
$272K Sell
950
-65
-6% -$16.7K 0.15% 93
2021
Q4
$280K Hold
1,015
0.16% 91
2021
Q3
$235K Hold
1,015
0.14% 98
2021
Q2
$233K Hold
1,015
0.14% 102
2021
Q1
$190K Hold
1,015
0.13% 104
2020
Q4
$171K Hold
1,015
0.12% 107
2020
Q3
$150K Sell
1,015
-100
-9% -$15.5K 0.12% 88
2020
Q2
$183K Hold
1,115
0.15% 85
2020
Q1
$155K Sell
1,115
-157
-12% -$21.6K 0.16% 79
2019
Q4
$167K Sell
1,272
-409
-24% -$47.4K 0.15% 86
2019
Q3
$188K Sell
1,681
-218
-11% -$24.3K 0.11% 114
2019
Q2
$210K Sell
1,899
-2,928
-61% -$345K 0.11% 119
2019
Q1
$626K Buy
4,827
+21
+0.4% +$2.55K 0.33% 68
2018
Q4
$556K Sell
4,806
-530
-10% -$59.2K 0.28% 72
2018
Q3
$573K Sell
5,336
-1,295
-20% -$129K 0.26% 73
2018
Q2
$566K Buy
6,631
+4,625
+231% +$380K 0.28% 75
2018
Q1
$155K Sell
2,006
-72
-3% -$5.8K 0.08% 136
2017
Q4
$176K Buy
2,078
+200
+11% +$17K 0.08% 145
2017
Q3
$161K Buy
1,878
+595
+46% +$48.8K 0.08% 126
2017
Q2
$106K Sell
1,283
-200
-13% -$16.3K 0.06% 175
2017
Q1
$127K Hold
1,483
0.07% 162
2016
Q4
$114K Hold
1,483
0.07% 159
2016
Q3
$119K Hold
1,483
0.07% 155
2016
Q2
$117K Buy
+1,483
New +$112K 0.07% 158

Other funds holding LLY

Cribstone Capital Management's LLY Position: Q4 2022 in Review

Cribstone Capital Management reduced its Eli Lilly (LLY) stake by 0.52% in Q4 2022, selling an estimated $1.77K and leaving 950 shares worth $348K. The position accounts for 0.2% of the portfolio, ranked #89.

Cribstone Capital Management first reported a position in LLY in Q2 2016 and has held it in 27 quarters since. The position peaked at $626K in Q1 2019. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Cribstone Capital Management held 950 shares of Eli Lilly worth $348K as of Q4 2022.
  • Cribstone Capital Management sold 5 Eli Lilly shares in Q4 2022, an estimated $1.77K.
  • Eli Lilly made up 0.2% of Cribstone Capital Management's portfolio in Q4 2022, its #89 holding.
  • Cribstone Capital Management first reported a position in Eli Lilly in Q2 2016 and has held it in 27 quarters since.
  • Cribstone Capital Management's Eli Lilly position peaked at $626K in Q1 2019.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.